Skip to main content
. 2013 Aug 9;14(1):83. doi: 10.1186/1465-9921-14-83

Table 4.

Effects for workplace ETS exposure (n/y), the SNPs, and the interaction of GSTO SNPs (recessive model) with workplace ETS exposure on FEV1

  FEV1 (ml) b (95% CI)  
Gene
Variable
All
Never smokers
Ever smokers
 
N, in analysis
7149
3051
4098
GSTO1
Workplace ETS
−26 (−71 ; 20)
−51 (−126 ; 25)
−17 (−73 ; 40)
 
rs4925
8 (−34 ; 50)
78 (17 ; 138)
−48 (−105 ; 9)
 
ETS*rs4925
$-173 (−313 ; -33)*
$-281 (−498 ; -64)*
−84 (−268 ; 100)
GSTO1
Workplace ETS
−22 (−68 ; 25)
−41 (−117 ; 36)
−15 (−73 ; 43)
 
rs1147611
8 (−27 ; 42)
49 (0 ; 99)#
−29 (−78 ; 19)
 
ETS*rs1147611
$-151 (−272 ; -31)*
$-286 (−486 ; -87)**
−65 (−218 ; 87)
GSTO2
Workplace ETS
−21 (−67 ; 25)
−41 (−118 ; 36)
−14 (−72 ; 44)
 
rs156697
8 (−28 ; 44)
50 (−1 ; 100)
−29 (−79 ; 20)
 
ETS*rs156697
$-170 (−295 ; -46)**
$-287 (−486 ; -88)**
−84 (−245 ; 77)
GSTO2
Workplace ETS
−17 (−63 ; 28)
−41 (−117 ; 35)
−9 (−66 ; 48)
 
rs156699
6 (−32 ; 45)
43 (−12 ; 98)
−26 (−79 ; 28)
  ETS*rs156699 $-218 (−349 ; -87)** $-318 (−525;-111)** −140 (−311 ; 30)

The linear regression model for the whole group was adjusted for sex, age, height, weight, current, ex-smoking and packyears smoked. Consequently we stratified by smoking status (never/ever) and adjusted for the other possible confounders.

*p-value<0.05 **p-value<0.01.

$significant after FDR correction for multiple testing.